Serum Infliximab Cutoff trough Level Values for Maintaining Hematological Remission in Pediatric Inflammatory Bowel Disease

BACKGROUND/AIMS: Infliximab (IFX) often loses its therapeutic effect in initial responders with inflammatory bowel disease (IBD) over time. Low serum IFX trough levels (TLs) are linked to poor clinical response and outcomes. Maintenance of optimal therapeutic IFX concentrations is important for sust...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, So Yoon, Kang, Ben, Choe, Yon Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743797/
https://www.ncbi.nlm.nih.gov/pubmed/30970435
http://dx.doi.org/10.5009/gnl18129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743797/
https://www.ncbi.nlm.nih.gov/pubmed/30970435
http://dx.doi.org/10.5009/gnl18129

Ejemplares similares